Synergy Pharmaceuticals equityholders group appeals financing order

By Caroline Salls

Pittsburgh, March 12 – Synergy Pharmaceuticals Inc.’s official committee of equity security holders appealed the order approving the company’s debtor-in-possession financing, according to a notice filed Tuesday with the U.S. Bankruptcy Court for the Southern District of New York.

The financing was approved by the court on Feb. 26.

Synergy is a New York-based biopharmaceutical company focused on the development and commercialization of novel gastrointestinal therapies. The company filed bankruptcy on Dec. 12 under Chapter 11 case number 18-14010.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.